本文關(guān)鍵詞： 血管性輕度認(rèn)知功能障礙 丁苯酞 S MBP　出處：《中國(guó)醫(yī)院藥學(xué)雜志》2017年09期 　論文類(lèi)型：期刊論文

【摘要】：目的:探討丁苯酞軟膠囊治療血管性輕度認(rèn)知功能障礙的臨床療效以及對(duì)血漿MBP、S100濃度的影響。方法:將60例血管性輕度認(rèn)知障礙患者(按隨機(jī)數(shù)字表法)隨機(jī)分為2組,每組30人,治療組給予基礎(chǔ)藥物治療加口服丁苯酞軟膠囊治療,對(duì)照組給予基礎(chǔ)藥物,療程為12個(gè)月,于治療前、治療后第6個(gè)月、12個(gè)月分別對(duì)患者進(jìn)行簡(jiǎn)易精神狀態(tài)檢查(MMSE),測(cè)定S100和MBP濃度。結(jié)果:治療組6個(gè)月、12個(gè)月時(shí)MMSE評(píng)分與對(duì)照組比較有明顯改善,S100和MBP濃度顯著下降。結(jié)論:丁苯酞軟膠囊可有效提高血管性輕度認(rèn)知功能障礙患者M(jìn)MSE評(píng)分并降低S100和MBP濃度,具有神經(jīng)保護(hù)作用。
[Abstract]:Objective: to investigate the clinical effect of butyphthalide soft capsule in the treatment of vascular mild cognitive impairment and its effect on plasma MBPnS100. Methods: sixty patients with mild vascular cognitive impairment were randomly divided into two groups. Each group of 30 people, the treatment group was treated with basic drugs plus oral butyphthalide soft capsule treatment, the control group was given basic drugs for 12 months, before treatment, After 6 months and 12 months of treatment, the patients were examined with simple mental state and the concentrations of S100 and MBP were measured. Results: the MMSE score of the treatment group at 6 months and 12 months after treatment was significantly improved compared with that of the control group. Conclusion: butyphthalide soft capsule can effectively improve the MMSE score and reduce the concentration of S 100 and MBP in patients with vascular mild cognitive impairment. It has neuroprotective effect.
【作者單位】： 河北省人民醫(yī)院;
【分類(lèi)號(hào)】：R749.13

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 熊鵬;吳秋霞;王繼才;李國(guó)華;曾勇;張樹(shù)良;;精神分裂癥患者血清GFAP與MBP水平的變化[J];中國(guó)神經(jīng)精神疾病雜志;2013年01期

2 ;[J];;年期

相關(guān)碩士學(xué)位論文 前1條

1 李明;NGF-β、IL-1β、MBP與精神分裂癥臨床癥狀的相關(guān)性研究[D];昆明醫(yī)科大學(xué);2015年

，

本文編號(hào)：1556121